• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国浙江省苯丙氨酸羟化酶缺乏症的突变和表型谱。

Mutational and phenotypic spectrum of phenylalanine hydroxylase deficiency in Zhejiang Province, China.

机构信息

Division of Medical Genetics and Genomics, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.

Institute of Genetics and Department of Human Genetics, Zhejiang University School of Medicine, Hangzhou, 310058, China.

出版信息

Sci Rep. 2018 Nov 20;8(1):17137. doi: 10.1038/s41598-018-35373-9.

DOI:10.1038/s41598-018-35373-9
PMID:30459323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6244417/
Abstract

Phenylalanine hydroxylase deficiency (PAHD), one of the genetic disorders resulting in hyperphenylalaninemia, has a complex phenotype with many variants and genotypes among different populations. Here, we describe the mutational and phenotypic spectrum of PAHD in a cohort of 420 patients from neonatal screening between 1999 and 2016. The observed phenotypes comprised 43.57% classic phenylketonuria, 33.10% mild PKU, and 23.33% mild hyperphenylalaninemia, with an overall PAHD incidence of 1 in 20,445. Genetic testing was performed for 209 patients and 72 variants including seven novel variants were identified. These included two synonymous and five pathogenic nonsynonymous variants (p.S36*, p.T186I, p.L255W, p.F302V and p.R413H). The most common variant among all patients was p.R243Q, followed by p.R241C, p.Y204C, p.R111* and c.442-1G > A. Variants p.R53H and p.F392I occurred only in MHP with 19.3% and 8.0% of the observed alleles respectively. The genotypes p.[R241C];[R243Q], p.[R243Q];[R243Q], and p.[Y204C];[R243Q] were abundant across all PAHD patients. The distributions of the null allele and the three defined genotypes, null/null, null/missense, and missense/missense, were significantly different between the cPKU and mPKU patients. However, no significant differences were found between mPKU and MHP patients, indicating that other modifier factors influence the phenotypic outcome in these patients. The data presented here will provide a valuable tool for improved genetic counseling and management of future cases of PAHD in China.

摘要

苯丙氨酸羟化酶缺乏症(PAHD)是导致高苯丙氨酸血症的遗传疾病之一,在不同人群中具有复杂的表型,存在许多变异体和基因型。在这里,我们描述了 1999 年至 2016 年间新生儿筛查队列中 420 例患者的 PAHD 突变和表型谱。观察到的表型包括 43.57%的经典苯丙酮尿症、33.10%的轻度苯丙酮尿症和 23.33%的轻度高苯丙氨酸血症,PAHD 的总发病率为每 20445 例 1 例。对 209 例患者进行了基因检测,发现了 72 种变异体,包括 7 种新的变异体。其中包括两个同义变异体和五个致病性非同义变异体(p.S36*、p.T186I、p.L255W、p.F302V 和 p.R413H)。所有患者中最常见的变异体是 p.R243Q,其次是 p.R241C、p.Y204C、p.R111*和 c.442-1G > A。变异体 p.R53H 和 p.F392I 仅在 MHP 中出现,其等位基因分别占观察到的等位基因的 19.3%和 8.0%。基因型 p.[R241C];[R243Q]、p.[R243Q];[R243Q]和 p.[Y204C];[R243Q]在所有 PAHD 患者中均大量存在。纯合缺失/缺失、杂合缺失/错义、纯合错义/错义三种基因型在 cPKU 和 mPKU 患者中的分布有显著差异。然而,mPKU 和 MHP 患者之间没有发现显著差异,表明其他修饰因子影响这些患者的表型结果。本研究提供的资料将为中国未来 PAHD 病例的遗传咨询和管理提供有价值的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8460/6244417/bb8a8cd7f926/41598_2018_35373_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8460/6244417/bb8a8cd7f926/41598_2018_35373_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8460/6244417/bb8a8cd7f926/41598_2018_35373_Fig1_HTML.jpg

相似文献

1
Mutational and phenotypic spectrum of phenylalanine hydroxylase deficiency in Zhejiang Province, China.中国浙江省苯丙氨酸羟化酶缺乏症的突变和表型谱。
Sci Rep. 2018 Nov 20;8(1):17137. doi: 10.1038/s41598-018-35373-9.
2
[Genotype and phenotype correlation of phenylalanine hydroxylase deficiency among patients from Henan].[河南患者苯丙氨酸羟化酶缺乏症的基因型与表型相关性]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Jun;33(3):300-5. doi: 10.3760/cma.j.issn.1003-9406.2016.03.005.
3
Spectrum of PAH gene mutations and genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Shanxi province.山西省苯丙氨酸羟化酶缺乏症患者的 PAH 基因突变谱及基因型-表型相关性。
Brain Dev. 2021 Feb;43(2):220-229. doi: 10.1016/j.braindev.2020.08.012. Epub 2020 Sep 4.
4
Analysis of the genotype-phenotype correlation in patients with phenylketonuria in mainland China.中国大陆苯丙酮尿症患者基因型-表型相关性分析。
Sci Rep. 2018 Jul 26;8(1):11251. doi: 10.1038/s41598-018-29640-y.
5
Mutational spectrum of the phenylalanine hydroxylase gene in patients with phenylketonuria in the central region of China.中国中部地区苯丙酮尿症患者苯丙氨酸羟化酶基因的突变谱
Scand J Clin Lab Invest. 2018 May;78(3):211-218. doi: 10.1080/00365513.2018.1434898. Epub 2018 Feb 1.
6
[Correlation between genotypes and biochemical phenotypes of phenylalanine hydroxylase in patients with phenylketonuria].苯丙酮尿症患者苯丙氨酸羟化酶基因型与生化表型的相关性
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Dec;29(6):635-41. doi: 10.3760/cma.j.issn.1003-9406.2012.06.003.
7
Characterization of phenylalanine hydroxylase gene variants and analysis of genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Fujian Province, Southeastern China.中国东南部福建省苯丙氨酸羟化酶缺乏症患者的苯丙氨酸羟化酶基因突变特征及基因型-表型相关性分析。
Mol Biol Rep. 2022 Nov;49(11):10409-10419. doi: 10.1007/s11033-022-07579-8. Epub 2022 Sep 14.
8
Comprehensive analyses of phenylalanine hydroxylase variants and phenotypic characteristics of patients in the eastern region of Türkiye.土耳其东部地区苯丙氨酸羟化酶变异体的综合分析及患者表型特征。
J Pediatr Endocrinol Metab. 2024 May 7;37(6):543-552. doi: 10.1515/jpem-2024-0091. Print 2024 Jun 25.
9
Variations in genotype-phenotype correlations in phenylalanine hydroxylase deficiency in Chinese Han population.中国汉族人群苯丙氨酸羟化酶缺乏症基因型-表型相关性的变异。
Gene. 2013 Oct 15;529(1):80-7. doi: 10.1016/j.gene.2013.07.079. Epub 2013 Aug 7.
10
Phenylalanine hydroxylase genotype-phenotype associations in the United States: A single center study.美国苯丙氨酸羟化酶基因型-表型相关性:一项单中心研究。
Mol Genet Metab. 2019 Dec;128(4):415-421. doi: 10.1016/j.ymgme.2019.09.004. Epub 2019 Sep 14.

引用本文的文献

1
Analysis of gene variation and long-term follow-up in children with phenylalanine hydroxylase deficiency diagnosed by newborn screening.新生儿筛查诊断的苯丙氨酸羟化酶缺乏症患儿的基因变异分析及长期随访。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Dec 7;52(6):701-706. doi: 10.3724/zdxbyxb-2023-0450.
2
Design of a silicon Mach-Zehnder modulator via deep learning and evolutionary algorithms.基于深度学习和进化算法的硅基马赫-曾德尔调制器设计
Sci Rep. 2023 Sep 5;13(1):14662. doi: 10.1038/s41598-023-41558-8.
3
Recent Advances in Phenylketonuria: A Review.

本文引用的文献

1
Reassessing the significance of the PAH c.158G>A (p.Arg53His) variant in patients with hyperphenylalaninemia.重新评估高苯丙氨酸血症患者中PAH基因c.158G>A(p.Arg53His)变异的意义。
J Pediatr Endocrinol Metab. 2017 Oct 26;30(11):1211-1218. doi: 10.1515/jpem-2017-0158.
2
Spectrum of PAH gene variants among a population of Han Chinese patients with phenylketonuria from northern China.中国北方汉族苯丙酮尿症患者群体中PAH基因变异谱
BMC Med Genet. 2017 Oct 5;18(1):108. doi: 10.1186/s12881-017-0467-7.
3
HGVS Recommendations for the Description of Sequence Variants: 2016 Update.
苯丙酮尿症的最新进展:综述
Cureus. 2023 Jun 15;15(6):e40459. doi: 10.7759/cureus.40459. eCollection 2023 Jun.
4
Expanded newborn screening for inherited metabolic disorders by tandem mass spectrometry in a northern Chinese population.中国北方人群中通过串联质谱法对遗传性代谢疾病进行扩大新生儿筛查。
Front Genet. 2022 Sep 30;13:801447. doi: 10.3389/fgene.2022.801447. eCollection 2022.
5
Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates.应用新一代测序(NGS) panel 于新生儿筛检可有效鉴定新生儿的先天疾病。
Orphanet J Rare Dis. 2022 Feb 21;17(1):66. doi: 10.1186/s13023-022-02231-x.
6
Neonatal screening and genotype-phenotype correlation of hyperphenylalaninemia in the Chinese population.中国人群高苯丙氨酸血症的新生儿筛查及基因型-表型相关性。
Orphanet J Rare Dis. 2021 May 12;16(1):214. doi: 10.1186/s13023-021-01846-w.
7
Spectrum analysis of inborn errors of metabolism for expanded newborn screening in a northwestern Chinese population.中国西北地区扩大新生儿筛查的遗传代谢病谱分析。
Sci Rep. 2021 Jan 29;11(1):2699. doi: 10.1038/s41598-021-81897-y.
8
Cognitive analysis of metabolomics data for systems biology.用于系统生物学的代谢组学数据的认知分析。
Nat Protoc. 2021 Mar;16(3):1376-1418. doi: 10.1038/s41596-020-00455-4. Epub 2021 Jan 22.
《人类基因组变异协会(HGVS)序列变异描述建议:2016年更新》
Hum Mutat. 2016 Jun;37(6):564-9. doi: 10.1002/humu.22981. Epub 2016 Mar 25.
4
Genetics of Phenylketonuria: Then and Now.苯丙酮尿症的遗传学:过去与现在
Hum Mutat. 2016 Jun;37(6):508-15. doi: 10.1002/humu.22980. Epub 2016 Mar 18.
5
First structure of full-length mammalian phenylalanine hydroxylase reveals the architecture of an autoinhibited tetramer.全长哺乳动物苯丙氨酸羟化酶的首个结构揭示了一种自抑制四聚体的结构。
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):2394-9. doi: 10.1073/pnas.1516967113. Epub 2016 Feb 16.
6
Mutational and phenotypical spectrum of phenylalanine hydroxylase deficiency in Denmark.丹麦苯丙氨酸羟化酶缺乏症的突变和表型谱
Clin Genet. 2016 Sep;90(3):247-51. doi: 10.1111/cge.12692. Epub 2015 Dec 12.
7
Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing.利用新一代测序技术对中国大陆人群苯丙酮尿症进行分子特征分析。
Sci Rep. 2015 Oct 27;5:15769. doi: 10.1038/srep15769.
8
Correlation between genotype and the tetrahydrobiopterin-responsive phenotype in Chinese patients with phenylketonuria.中国苯丙酮尿症患者的基因型与四氢生物蝶呤反应性表型之间的相关性
Pediatr Res. 2015 Dec;78(6):691-9. doi: 10.1038/pr.2015.167. Epub 2015 Aug 31.
9
[Consensus about the diagnosis and treatment of hyperphenylalaninemia].[关于高苯丙氨酸血症诊断与治疗的共识]
Zhonghua Er Ke Za Zhi. 2014 Jun;52(6):420-5.
10
Linking genotypes database with locus-specific database and genotype-phenotype correlation in phenylketonuria.苯丙酮尿症中基因型数据库与基因座特异性数据库的关联以及基因型-表型相关性
Eur J Hum Genet. 2015 Mar;23(3):302-9. doi: 10.1038/ejhg.2014.114. Epub 2014 Jun 18.